Factors associated with 60‐day readmission among inpatients with COVID‐19 at 21 United States health systems

Author:

Kirsch Julie A.12ORCID,Slutske Wendy S.12,McCarthy Danielle E.13,Smith Stevens S.13,Williams Brian S.134,Piasecki Thomas M.13,Conner Karen L.1,Fiore Michael C.13

Affiliation:

1. Center for Tobacco Research and Intervention University of Wisconsin‐Madison Madison Wisconsin USA

2. Department of Family Medicine and Community Health University of Wisconsin‐Madison Madison Wisconsin USA

3. Department of Medicine University of Wisconsin‐Madison Madison Wisconsin USA

4. Department of Pediatrics University of Wisconsin‐Madison Madison Wisconsin USA

Abstract

AbstractIdentifying patients at risk for readmission after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection could facilitate care planning and prevention. This retrospective cohort study of 60‐day readmission included 105 543 COVID‐19 patients at 21 US healthcare systems who were discharged alive between February 2020 and November 2021. Generalized linear mixed regression analyses tested predictors of 60‐day readmission and severity. The all‐cause readmission rate was 15% (95% confidence interval [CI] = 10%–21%), with 22% (95% CI = 18%–26%) of readmitted patients needing intensive care, and 6% (95% CI = 05%–07%) dying. Factors associated with readmission included male sex, government insurance, positive smoking history, co‐morbidity burden, longer index admissions, and diagnoses at index admission (e.g., cancer, chronic kidney disease, and liver disease). Death and intensive care rates at readmission declined postvaccine availability. Receiving at least two COVID‐19 vaccine doses, which were more common among older patients and those with comorbid conditions, was not independently associated with readmission but predicted a reduced risk of death at readmission. This retrospective cohort study identified factors associated with all‐cause readmission for patients re‐admitted to the same health system after hospitalization with SARS‐CoV‐2 infection. Patients who are male, who smoke, who have a higher comorbidity burden, and have government insurance may benefit from additional postacute care planning.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3